Takeda Simplifies Portfolio and Accelerates Deleveraging Through Two Divestitures

Takeda will focus on its key business areas – Gastroenterology (GI), Rare Diseases, Plasma-Derived Therapies, Oncology and Neuroscience.

Link to Full Article: Read Here